Literature DB >> 10705911

The relationship between menstrual cycle phases and suicide attempts.

E Baca-García1, C Díaz-Sastre, J de Leon, J Saiz-Ruiz.   

Abstract

OBJECTIVE: The validity of prior studies on the menstrual cycle and suicide attempts assumes that suicidal women accurately describe their cycles. The three objectives of this study were 1) to explore whether prior inconsistencies are due to the effects of sample selection and method of assessment of the menstrual cycle, 2) to assess the relationship between the menstrual cycle phase and suicide attempts, and 3) to establish the role of sexual hormones in suicide attempts.
METHODS: The original sample included 134 women who came to the emergency room of a general hospital after a suicide attempt. One hundred eight female blood donors were recruited as control subjects. The menstrual cycle was divided into follicular, midcycle, and luteal phases using two clinical methods and serum hormonal assessment. Dividing the follicular phase into menstrual and nonmenstrual phases was also considered.
RESULTS: Two of 11 previously used sampling methods produced a sample size similar to that of the hormonal assessment. kappa values between the two clinical and the endocrinological methods were low (0.40-0.50). The number of suicide attempts during the follicular phase (particularly during the menstrual phase) was significantly higher than expected.
CONCLUSIONS: Despite the inability to control for other variables and limitations, the results of this study suggest that sample selection could introduce biases and that studies relating psychiatric symptomatology and menstrual cycle phases need to use hormonal determinations. New studies are needed to verify that suicide attempts are more frequent during the follicular phase (particularly during the menstrual phase).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705911     DOI: 10.1097/00006842-200001000-00008

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  7 in total

1.  Premenstrual symptoms and luteal suicide attempts.

Authors:  Enrique Baca-Garcia; Carmen Diaz-Sastre; Antonio Ceverino; Eloy García Resa; Maria A Oquendo; Jerónimo Saiz-Ruiz; Jose de Leon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

2.  Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Authors:  Tory A Eisenlohr-Moul; C Nathan DeWall; Susan S Girdler; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2015-03-30       Impact factor: 3.251

Review 3.  A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

4.  Age of first suicide attempt in men and women: an admixture analysis.

Authors:  Hilario Blasco-Fontecilla; Analucia A Alegria; David Delgado-Gomez; Teresa Legido-Gil; Jeronimo Saiz-Ruiz; Maria A Oquendo; Enrique Baca-Garcia
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  Recurrent suicide attempt and female hormones.

Authors:  Seyed Ghafur Mousavi; Shima Bateni; Mohammad Reza Maracy; Farahnaz Mardanian; Seyedeh Hakimeh Mousavi
Journal:  Adv Biomed Res       Date:  2014-09-30

6.  Aberrant telomere length and mitochondrial DNA copy number in suicide completers.

Authors:  Ikuo Otsuka; Takeshi Izumi; Shuken Boku; Atsushi Kimura; Yuan Zhang; Kentaro Mouri; Satoshi Okazaki; Kyoichi Shiroiwa; Motonori Takahashi; Yasuhiro Ueno; Osamu Shirakawa; Ichiro Sora; Akitoyo Hishimoto
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

Review 7.  Animal models to improve our understanding and treatment of suicidal behavior.

Authors:  T D Gould; P Georgiou; L A Brenner; L Brundin; A Can; P Courtet; Z R Donaldson; Y Dwivedi; S Guillaume; I I Gottesman; S Kanekar; C A Lowry; P F Renshaw; D Rujescu; E G Smith; G Turecki; P Zanos; C A Zarate; P A Zunszain; T T Postolache
Journal:  Transl Psychiatry       Date:  2017-04-11       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.